Medical Research News

Nursing

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mitchell D – Encouraging news about adult clinical trials involving the novel influenza A (H1N1) vaccine could boost uptake levels, but by how much remains to be seen. Uptake for the new vaccine possibly will be similar to that of seasonal flu vaccine. In other words, relatively low. Seasonal influenza vaccine is recommended for more than 80 percent of the U.S. population, but less than 40 percent of Americans receive the vaccine each year. Preliminary data from the clinical trials indicate that health care workers who are immunized with the new H1N1 vaccine will be taking a big step toward protecting themselves, their patients and their co–workers. The newly licensed H1N1 vaccines induce a robust immune response in most healthy adults just eight to 10 days after a single dose of unadjuvanted vaccine containing 15 micrograms of antigen.

Related Articles

Update on 2009 pandemic influenza A (H1N1) virus
Cleveland Clinic Journal of Medicine, 10/05/09    Relevance Score: 99%

H1N1 vaccine shortage leaves doctors managing crowds, anxieties
American Medical News, 11/06/09    Relevance Score: 98%

H1N1 Vaccine Production, Availability Increasing Slowly
American Family Physician, 11/02/09    Relevance Score: 98%

H1N1 Vaccine Deliveries Begin. Early Doses to Arrive This Week
American Family Physician, 10/07/09    Relevance Score: 98%

One Dose of H1N1 Vaccine Immunogenic in High Percentage of Youth Ages 10 to 17. Younger Children Likely Will Need Two Doses
American Family Physician, 10/05/09    Relevance Score: 98%

Today in Immuno/Infectious Dz...keeping you current

Invasive Pneumococcal Infections among Vaccinated Children in the United States
The Journal of Pediatrics, 12/08/09

Hepatitis C Treatment Concomitant To Chemotherapy As "Salvage" Therapy in Children With Hematologic Malignancies
The Pediatric Infectious Disease Journal, 12/08/09

In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii
The Journal of Antibiotics, 12/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address